Back to Search
Start Over
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy
- Source :
- Cardiovascular Research, 99(3), 432-441. Oxford University Press, Cardiovascular Research, Witjas-Paalberends, E R, Piroddi, N, Stam, C J, van Dijk, S J, Oliviera, V S, Ferrara, C, Scellini, B, Hazebroek, M, ten Cate, F J, van Slegtenhorst, M, dos Remedios, C, Niessen, H W M, Tesi, C, Stienen, G J M, Heymans, S, Michels, M, Poggesi, C & van der Velden, J 2013, ' Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy ', Cardiovascular Research, vol. 99, no. 3, pp. 432-441 . https://doi.org/10.1093/cvr/cvt119, Cardiovascular Research; Vol 99
- Publication Year :
- 2013
-
Abstract
- Aims Familial hypertrophic cardiomyopathy (HCM), frequently caused by sarcomeric gene mutations, is characterized by cellular dysfunction and asymmetric left-ventricular (LV) hypertrophy. We studied whether cellular dysfunction is due to an intrinsic sarcomere defect or cardiomyocyte remodelling. Methods and results Cardiac samples from 43 sarcomere mutation-positive patients (HCMmut: mutations in thick ( MYBPC3 , MYH7 ) and thin ( TPM1 , TNNI3 , TNNT2 ) myofilament genes) were compared with 14 sarcomere mutation-negative patients (HCMsmn), eight patients with secondary LV hypertrophy due to aortic stenosis (LVHao) and 13 donors. Force measurements in single membrane-permeabilized cardiomyocytes revealed significantly lower maximal force generating capacity (Fmax) in HCMmut (21 ± 1 kN/m2) and HCMsmn (26 ± 3 kN/m2) compared with donor (36 ± 2 kN/m2). Cardiomyocyte remodelling was more severe in HCMmut compared with HCMsmn based on significantly lower myofibril density (49 ± 2 vs. 63 ± 5%) and significantly higher cardiomyocyte area (915 ± 15 vs. 612 ± 11 μm2). Low Fmax in MYBPC3 mut, TNNI3 mut, HCMsmn, and LVHao was normalized to donor values after correction for myofibril density. However, Fmax was significantly lower in MYH7 mut, TPM1 mut, and TNNT2 mut even after correction for myofibril density. In accordance, measurements in single myofibrils showed very low Fmax in MYH7 mut, TPM1 mut, and TNNT2 mut compared with donor (respectively, 73 ± 3, 70 ± 7, 83 ± 6, and 113 ± 5 kN/m2). In addition, force was lower in MYH7 mut cardiomyocytes compared with MYBPC3 mut, HCMsmn, and donor at submaximal [Ca2+]. Conclusion Low cardiomyocyte Fmax in HCM patients is largely explained by hypertrophy and reduced myofibril density. MYH7 mutations reduce force generating capacity of sarcomeres at maximal and submaximal [Ca2+]. These hypocontractile sarcomeres may represent the primary abnormality in patients with MYH7 mutations.
- Subjects :
- Adult
Male
Sarcomeres
congenital, hereditary, and neonatal diseases and abnormalities
medicine.medical_specialty
Myofilament
Physiology
TNNT2
Cardiomyopathy
TPM1
Cell Enlargement
030204 cardiovascular system & hematology
Gene mutation
Contractility
Sarcomere
Muscle hypertrophy
Young Adult
03 medical and health sciences
0302 clinical medicine
Myofibrils
SDG 3 - Good Health and Well-being
Physiology (medical)
Internal medicine
Cardiomyopathy, Hypertrophic, Familial
medicine
Humans
Myocytes, Cardiac
cardiovascular diseases
Aged
030304 developmental biology
0303 health sciences
Myosin Heavy Chains
Chemistry
Hypertrophy
Middle Aged
Fibrosis
Myocardial Contraction
Mutation
cardiovascular system
Cardiology
Calcium
Female
MYH7
Cardiology and Cardiovascular Medicine
Myofibril
Sarcomere proteins
Cardiac Myosins
Subjects
Details
- Language :
- English
- ISSN :
- 00086363
- Volume :
- 99
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Cardiovascular Research
- Accession number :
- edsair.doi.dedup.....c02ef51926b9ba9e52e62f4701aecb41